Xi Wang

Clinical Studies of Breast Oncology. Dr. Wang is experienced with breast cancer surgery (radical surgery, and comprehensive treatment of mammary gland reconstruction), chemotherapy, endocrine treatme...

Jun Tang

Dr. Tang has engaged in clinical breast cancer service for over 10 years.He is the member of National Breast Cancer and Breast-Conserving Treatment and Sentinel Lymph Node Biopsy Association and the ...

Xiaoming Xie

Dr. Xiaoming Xie is Surgeon and Chairman of the Department of Breast Oncology and Director of the Laboratory of Cancer Biotechnology in the State Key Laboratory of Oncology in Southern China, Sun Yat...

Mingtian Yang

Clinical Studies of Breast Oncology Dr. Mingtian Yang has extensive experience for esophageal cancer, lung cancer and mediastinal tumor, breast cancer. He is the chief specialist of breast cancer.197...

Weidong Wei

After he graduated from Tongji University in 1987, Dr. Wei worked as a surgeon in general surgery and burns surgery. In 1999, Dr. Wei started to work as a oncology surgeon, and he was specialized in ...

Xiangsheng Xiao

1. Early diagnosis of breast cancer; 2. Diagnosis and treatment of nipple discharge; 3. Minimally invasive operation of breast lump; 4. Breast conserving operation for breast cancer; 5. Surgical reco...

Jin Wang

Dr. Jin Wang is currently an Associate Professor in the Department of Breast Oncology at SYSUCC. She specializes in breast oncology and is a renowned young oncological surgeon in China. Dr. Jin Wang ...

Zeming Xie

Anli Yang

After getting his bachelor’s degree of medicine in Zhongshan School of Medicine (equivalent to an M.D. in the USA), Dr. Yang was recommended for admission to the First Affiliated Hospital of SYSU, ma...

Li Ning

Dr. Li is an associate chief physician in the department of Breast Oncology at Sun Yat-sen University Cancer Center. He is a graduate student supervisor of Sun Yat-sen University. He engaged in surge...

Zou Xu-xia-zi

Engaged in research on comprehensive treatment of breast cancer, immunotherapy for triple-negative breast cancer, and postoperative breast reconstruction for breast cancer.